Engineered Human tmpk/AZT As a Novel Enzyme/Prodrug Axis for Suicide Gene Therapy
Open Access
- 1 May 2007
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (5) , 962-970
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Specific pharmacological dimerization of KDR in lentivirally transduced human hematopoietic cells activates antiapoptotic and proliferative mechanismsThe FASEB Journal, 2005
- Efficient transfer of PSA and PSMA cDNAs into DCs generates antibody and T cell antitumor responses in vivoCancer Gene Therapy, 2005
- CD3/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effectsBlood, 2003
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Potentiating AZT activation: structures of wild-type and mutant human thymidylate kinase suggest reasons for the mutants’ improved kinetics with the HIV prodrug metabolite AZTMP 1 1Edited by J. KarnJournal of Molecular Biology, 2000
- In VivoToxicity of Foscarnet and Zidovudine Given Alone or in CombinationToxicology and Applied Pharmacology, 1996
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- The CD19/CD21 signal transduction complex of B lymphocytesImmunology Today, 1994
- Acquired immunodeficiency syndrome and heart disease: The present and the futureAmerican Heart Journal, 1989
- Anticellular Effects of 9-(2-Hydroxyethoxymethyl) Guanine Against Herpes Simplex Virus-transformed CellsJournal of General Virology, 1979